AACR IO 2026 Keynote Highlights: Cancer Vaccines Are Here, and Upgrading T Cells To Thrive in the Tumor Microenvironment
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Elizabeth M. Jaffee and Philip D. Greenberg opened AACR IO 2026 with a look at cancer vaccines and the...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...
The American Association for Cancer Research (AACR) and its Minorities in Cancer Research (MICR) membership group today issued a...
In 2012, Carl June, MD, a pioneer in the development of chimeric antigen receptor (CAR) T-cell therapy, helped treat Emily Whitehead, the...
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...
This month, the editors of the AACR’s journals have decided to feature a clinical trial evaluating prolonged treatment with ibrutinib for patients with chronic...
The prognosis for a patient with cancer depends on several factors, including the cancer’s stage. Patients whose cancers are diagnosed at earlier...
As the murders of George Floyd, Breonna Taylor, and others exposed racial inequities in America, many sectors of society...
As the COVID-19 pandemic began crossing the globe, scientists from many disciplines anticipated its scope and deployed their research...
“The development of tests that can identify individuals actively infected with SARS-CoV-2 is of obvious and utmost importance for...
At the American Association for Cancer Research (AACR), we know that our mission to prevent and cure all cancers must encompass all...